A Phase 1 Drug-drug Interaction Study in Healthy Volunteers

NCT02227173 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug-drug Interaction Study

Interventions

DRUG: BMS-986020
DRUG: Montelukast
DRUG: Flurbiprofen
DRUG: Digoxin

Sponsor

Bristol-Myers Squibb